01The problem is not the product. It is the name
In Chinese-language markets Profhilo is almost always referred to by a nickname meaning the five-point lifting injection. The word lifting sits right in the middle of it, so a patient reasonably expects the contour to move — the jawline to sharpen, the midface to sit higher.
Within that same market, the more measured commentators say something quite different. Several state directly that it has no lifting function and is not a lifting injection at all; one describes it as, in essence, high-concentration hyaluronic acid mesotherapy.
Meanwhile promotional material puts it in the same sentence as thread lifting.
These positions are too far apart to reconcile, and the gap is not really about honesty. It is that the nickname describes an outcome while the product delivers a mechanism, and the two were never the same thing.
The people who pay for that gap are the ones who had the treatment and felt that nothing happened.
02What it actually does to the skin
Profhilo is a high-concentration hyaluronic acid made without a chemical crosslinker. Two millilitres carry sixty-four milligrams of hyaluronic acid, combining high and low molecular weight fractions through a patented thermal hybrid process rather than a chemical one.
Because it is not crosslinked, it behaves differently in tissue. A crosslinked filler holds its shape and creates volume where it is placed.
A non-crosslinked preparation spreads. So what changes is the condition of the skin itself — hydration, light reflection, texture, fine lines and overall firmness — rather than the position of anything underneath it.
The small number of injection points, placed deeply, exists so the material can diffuse from a few well-chosen positions. It is a distribution strategy, not a lifting technique.
Read that way, everything about the product is consistent; read through the nickname, it looks like an underperforming lift.
03Who tends to be satisfied, and who tends not to be
The pattern is fairly consistent, and it follows directly from the mechanism.
- Often satisfied: people past their early thirties whose skin has become drier, duller and less resilient, where the complaint is that the face looks tired rather than that it has fallen.
- Often disappointed: younger patients whose skin is already plump and reflective. There is simply less room to improve, and the change may not be visible.
- Usually the wrong choice: anyone whose actual concern is a blurred jawline or descended midface. That is structural, and no injection of this type addresses it.
- Frequently mixed: people who have both problems at once, which is most people past a certain age. The sensible approach is to treat them as two separate questions rather than hoping one product covers both.
04A better question than which product
The useful conversation does not start with a product name. It starts with separating two things that both get described as looking older: has the quality of the skin changed, or has the structure moved?
If it is quality, this class of treatment is aimed squarely at it. If it is structure, the honest answer is that this is not the tool, and a clinic that sells it to you anyway has chosen the sale over the outcome.
Most faces are some combination, which is why the order matters and why it is decided in person. What should not happen is that a nickname decides it for you.
Ready to talk to our doctor?
Send a photo or describe your concern on LINE — we'll suggest a treatment plan and price range before you visit.